X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4227) 4227
Publication (469) 469
Newsletter (138) 138
Book Chapter (49) 49
Book Review (14) 14
Conference Proceeding (5) 5
Book / eBook (4) 4
Dissertation (2) 2
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3449) 3449
index medicus (1599) 1599
animals (1481) 1481
male (1201) 1201
female (1188) 1188
oncology (1075) 1075
mice (940) 940
cancer (790) 790
lymphomas (773) 773
hematology (736) 736
adult (674) 674
middle aged (647) 647
precursor cell lymphoblastic leukemia-lymphoma - enzymology (604) 604
apoptosis (574) 574
cell line, tumor (568) 568
lymphoma (557) 557
child (530) 530
aged (497) 497
expression (489) 489
lymphoma - enzymology (480) 480
adolescent (446) 446
biochemistry & molecular biology (445) 445
cell biology (439) 439
leukemia (430) 430
tumor cells, cultured (426) 426
cell line (424) 424
phosphorylation (381) 381
research (370) 370
child, preschool (348) 348
mutation (345) 345
proteins (344) 344
activation (336) 336
apoptosis - drug effects (323) 323
immunohistochemistry (319) 319
genetic aspects (317) 317
pathology (303) 303
precursor cell lymphoblastic leukemia-lymphoma - genetics (301) 301
hemic and lymphatic diseases (289) 289
lymphoma, large b-cell, diffuse - enzymology (286) 286
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (286) 286
signal transduction (280) 280
antineoplastic agents - pharmacology (278) 278
analysis (277) 277
gene expression (276) 276
prognosis (276) 276
immunology (271) 271
research article (252) 252
enzymes (251) 251
lymphoma, b-cell - enzymology (248) 248
chemotherapy (244) 244
antineoplastic agents - therapeutic use (240) 240
acute lymphoblastic-leukemia (237) 237
kinases (236) 236
pharmacology & pharmacy (235) 235
gene (231) 231
article (230) 230
tumors (229) 229
care and treatment (222) 222
protein-tyrosine kinases - metabolism (220) 220
infant (213) 213
multidisciplinary sciences (211) 211
anaplastic lymphoma kinase (209) 209
cells (207) 207
lymphoma, non-hodgkin - enzymology (206) 206
health aspects (204) 204
protein kinase inhibitors - pharmacology (201) 201
aged, 80 and over (200) 200
b-lymphocytes - enzymology (200) 200
molecular sequence data (193) 193
neoplasms - enzymology (190) 190
enzyme activation (188) 188
gene expression regulation, neoplastic (184) 184
medicine (184) 184
base sequence (183) 183
non-hodgkins-lymphoma (180) 180
physiological aspects (178) 178
rats (176) 176
leukemia - enzymology (175) 175
medicine, research & experimental (175) 175
non-hodgkin's lymphomas (175) 175
dose-response relationship, drug (173) 173
enzyme inhibitors - pharmacology (173) 173
t-lymphocytes - enzymology (173) 173
cells, cultured (172) 172
kinetics (170) 170
genes (168) 168
lung neoplasms - enzymology (168) 168
signal transduction - drug effects (168) 168
precursor cell lymphoblastic leukemia-lymphoma - pathology (165) 165
protein kinase inhibitors - therapeutic use (165) 165
lymphoma - pathology (163) 163
time factors (163) 163
cell proliferation - drug effects (161) 161
phenotype (156) 156
protein (156) 156
lymphocytes (155) 155
treatment outcome (155) 155
flow cytometry (153) 153
lymphoma, large-cell, anaplastic - enzymology (152) 152
receptor protein-tyrosine kinases - genetics (152) 152
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4265) 4265
Chinese (39) 39
Russian (22) 22
Japanese (12) 12
French (11) 11
German (11) 11
Polish (8) 8
Czech (1) 1
Dutch (1) 1
Hungarian (1) 1
Italian (1) 1
Romanian (1) 1
Serbian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 1, pp. 44 - 50
Purpose Aurora A kinase (AAK) is overexpressed in aggressive lymphomas and can correlate with more histologically aggressive forms of disease. We therefore... 
SURVIVAL | IN-VITRO | ADVANCED SOLID TUMORS | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | ONCOLOGY | SYNTHETIC LETHAL | MYC | VINCRISTINE | MLN8237 | LEUKEMIA CELLS | NF-KAPPA-B | Burkitt Lymphoma - enzymology | Recurrence | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Aurora Kinase A - antagonists & inhibitors | Lymphoma, T-Cell - enzymology | Antineoplastic Agents - adverse effects | Adult | Female | Antineoplastic Agents - pharmacokinetics | Molecular Targeted Therapy - methods | Burkitt Lymphoma - drug therapy | Protein Kinase Inhibitors - pharmacokinetics | Azepines - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Drug Administration Schedule | Pyrimidines - administration & dosage | Lymphoma, Large B-Cell, Diffuse - enzymology | Lymphoma, Mantle-Cell - drug therapy | Treatment Outcome | Azepines - therapeutic use | Protein Kinase Inhibitors - administration & dosage | Lymphoma, T-Cell - drug therapy | Lymphoma, Mantle-Cell - enzymology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Lymphoma, Follicular - enzymology | Aged | Azepines - pharmacokinetics | Azepines - administration & dosage | Hema13 | ORIGINAL REPORTS
Journal Article
Blood, ISSN 0006-4971, 02/2010, Volume 115, Issue 5, pp. 1026 - 1036
Journal Article
Cancer Science, ISSN 1347-9032, 11/2016, Volume 107, Issue 11, pp. 1543 - 1549
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 06/2008, Volume 22, Issue 6, pp. 1139 - 1143
Peripheral T-cell lymphomas (PTCLs) are fatal in the majority of patients and novel treatments, such as protein tyrosine kinase (PTK) inhibition, are needed.... 
TARGET | ACTIVATION | Syk | ONCOLOGY | tyrosine kinase | TISSUE | MARKERS | peripheral T-cell lymphoma | FOLLICULAR LYMPHOMA | HEMATOLOGY | phosphorylation | EXPRESSION | Translocation, Genetic | Phosphorylation | Lymphoma, Extranodal NK-T-Cell - enzymology | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Child, Preschool | Male | Intracellular Signaling Peptides and Proteins - metabolism | Lymphoma, Large-Cell, Anaplastic - enzymology | Lymphoma, T-Cell, Cutaneous - genetics | Immunoenzyme Techniques | Lymphoma, Extranodal NK-T-Cell - genetics | Chromosomes, Human, Pair 9 - genetics | Protein-Tyrosine Kinases - genetics | Flow Cytometry | Aged, 80 and over | Adult | Female | Child | Intracellular Signaling Peptides and Proteins - genetics | Syk Kinase | Chromosomes, Human, Pair 5 - genetics | Lymphoma, Large-Cell, Anaplastic - genetics | Lymphoma, T-Cell, Peripheral - genetics | Immunophenotyping | In Situ Hybridization, Fluorescence | Blotting, Western | Lymphoma, T-Cell, Peripheral - enzymology | Lymphoma, T-Cell, Cutaneous - pathology | Lymphoma, T-Cell, Cutaneous - enzymology | Tyrosine - metabolism | Lymphoma, Extranodal NK-T-Cell - pathology | Lymphoma, T-Cell, Peripheral - pathology | Adolescent | Aged | Lymphoma, Large-Cell, Anaplastic - pathology | Control | T cell lymphoma | Protein tyrosine kinase | Genetic aspects | Research | Diagnosis | Gene expression | Drug therapy
Journal Article